Share This Video

Injectables in the Treatment of Type 2 Diabetes: A Guide to Overcoming Patient Concerns

In this video, Dr. LaSalle discusses the integration of injectable therapy into a treatment plan for diabetes that minimizes fear and maximizes therapeutic benefit.
James R. LaSalle, DO
Medical Director, Medical Arts Center
Excelsior Springs, Missouri
James R. LaSalle, DO


  1. American Diabetes Association. Standards of medical care in diabetes—2009. Diabetes Care. 2009;32(suppl 1):S13-S61.
  2. Brod M, Kongsø JH, Lessard S, Christensen TL. Psychological insulin resistance: patient beliefs and implications for diabetes management. Qual Life Res. 2009;18(1):23-32.
  3. Age-adjusted percentage of adults with diabetes using diabetes medication, by type of medication, United States, 1997-2011. US Centers for Disease Control and Prevention Web site. Revised November 20, 2012. Accessed October 7, 2013.
  4. Korytkowski M. When oral agents fail: practical barriers to starting insulin. Int J Obes Relat Metab Disord. 2002;26(suppl 3):S18-S24.
  5. Inzucchi SE, Bergenstal RM, Buse JB, et al; American Diabetes Association (ADA); European Association for the Study of Diabetes (EASD). Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care. 2012;35(6):1364-1379.
  6. Polonsky WH, Jackson RA. What's so tough about taking insulin? Addressing the problem of psychological insulin resistance in type 2 diabetes. Clin Diabetes. 2004;22(3):147-150.
  7. Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV. Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem. Diabetes Care. 2005;28(10):2543-2545.
  8. Rubin RR, Peyrot M. Psychological issues and treatments for people with diabetes. J Clin Psychol. 2001;57(4):457-478.